 |
|
|
| |
Daclatasvir Plus Sofosbuvir With or Without Ribavirin for the Treatment of Chronic HCV in Patients Coinfected With HIV: Interim Results of a Multicenter European Compassionate Use Program (advanced liver disease)
|
| |
| |
Reported by Jules Levin
AASLD 2015 Nov 13-17 San Francisco
Rockstroh J,1 Welzel TM,2 Ingiliz P,3 Petersen J,4 Van der Valk M,5 Herzer K,6 Ferenci P,7 Gschwantler M,8 Cornberg M,9 Berg T,10 Spengler U,1 Weiland O,11 Klinker H,12 Peck-Radosavljevic M,7 Zhou Y,13 Jimenez-Exposito MJ,13 Zeuzem S2
1Universitatsklinikum Bonn, Bonn, Germany; 2Universitatsklinikum der Johann Wolfgang Goethe Universitat, Frankfurt, Germany; 3Medizinisches
Infektiologiezentrum, Berlin, Germany; 4IFI Institut fur Interdisziplinare Medizin, Hamburg, Germany; 5Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands; 6Universitatsklinikum Essen (AoR), Essen, Germany; 7Medizinische Universitat Wien, Vienna, Austria; 8Wilhelminenspital, Vienna, Austria; 9Medizinische Hochschule Hannover, Hannover, Germany; 10Universitatsklinikum Leipzig, Leipzig, Germany; 11Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden; 12Universitatsklinikum Wurzburg, Wurzburg, Germany; 13Bristol-Myers Squibb, Princeton, NJ, USA.
|
| |
|
|
|
|
|
